Adam Ioannou

2.3k total citations
78 papers, 547 citations indexed

About

Adam Ioannou is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Adam Ioannou has authored 78 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 30 papers in Molecular Biology and 21 papers in Nephrology. Recurrent topics in Adam Ioannou's work include Amyloidosis: Diagnosis, Treatment, Outcomes (29 papers), Parathyroid Disorders and Treatments (20 papers) and Cardiac pacing and defibrillation studies (13 papers). Adam Ioannou is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (29 papers), Parathyroid Disorders and Treatments (20 papers) and Cardiac pacing and defibrillation studies (13 papers). Adam Ioannou collaborates with scholars based in United Kingdom, United States and Italy. Adam Ioannou's co-authors include Julian D. Gillmore, Marianna Fontana, Constantinos G. Missouris, Rui Providência, Rishi Patel, Νικόλαος Παπαγεωργίου, Ana Martinez–Naharro, Aldostefano Porcari, Lucia Venneri and Yousuf Razvi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Adam Ioannou

64 papers receiving 535 citations

Peers

Adam Ioannou

CCM

NEPHR

ONCOL

RHEUM

Hiroki Usuku Japan

Rishi Patel United Kingdom

Luis Cueto-Garcia Mexico

Anggoro Budi Hartopo Indonesia

Álvaro Aceña Spain

Matthieu Berry France

Yafeng Zhou China

Ioannis Drosos Greece

Tanja Kero Sweden

Trejeeve Martyn United States

Hiroki Usuku Japan

Adam Ioannou

228 ×0.9

CCM

200 ×0.8

112 ×1.0

NEPHR

55 ×0.8

ONCOL

34 ×0.6

RHEUM

Citations per year, relative to Adam Ioannou Adam Ioannou (= 1×) peers Hiroki Usuku

Countries citing papers authored by Adam Ioannou

Since Specialization

Citations

This map shows the geographic impact of Adam Ioannou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Ioannou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Ioannou more than expected).

Fields of papers citing papers by Adam Ioannou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Ioannou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Ioannou. The network helps show where Adam Ioannou may publish in the future.

Co-authorship network of co-authors of Adam Ioannou

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Ioannou. A scholar is included among the top collaborators of Adam Ioannou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Ioannou. Adam Ioannou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vergaro, Giuseppe, Adam Ioannou, Giorgia Panichella, et al.. (2025). Current and emerging treatment options for transthyretin amyloid cardiomyopathy. Heart. 112(3). 129–138.

Ioannou, Adam, Sarah Cuddy, Sharmila Dorbala, et al.. (2025). The Last Decade in Cardiac Amyloidosis. JACC. Cardiovascular imaging. 18(4). 478–499. 11 indexed citations

Ioannou, Adam, et al.. (2025). P0931 Induction treatment with upadacitinib is associated with high rate of clinical response in patients with refractory Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 19(Supplement_1). i1747–i1748.

Razvi, Yousuf, Adam Ioannou, Aldostefano Porcari, et al.. (2025). EARLY DETECTION OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY THROUGH CARPAL TUNNEL DECOMPRESSION BIOPSIES -A PROSPECTIVE MULTICENTRE UNITED KINGDOM STUDY. Journal of the American College of Cardiology. 85(12). 4694–4694. 1 indexed citations

Patel, Rishi, Ana Martinez–Naharro, Yousuf Razvi, et al.. (2024). 5 Cardiovascular magnetic resonance (CMR) in transthyretin amyloid cardiomyopathy – a study of natural history and treatment repsonse. Abstracts. A2.1–A2. 1 indexed citations

Netti, Lucrezia, Adam Ioannou, Ana Martinez–Naharro, et al.. (2024). Microvascular Obstruction in Cardiac Amyloidosis. European Journal of Heart Failure. 27(12). 2948–2951. 4 indexed citations

Ioannou, Adam. (2024). Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. Heart International. 18(1). 30–37. 5 indexed citations

Ioannou, Adam, Yousuf Razvi, Aldostefano Porcari, et al.. (2023). Tracking multi-organ treatment response in systemic AL amyloidosis with cardiac magnetic resonance derived extracellular volume mapping. European Heart Journal - Cardiovascular Imaging. 24(Supplement_1). 1 indexed citations

Ioannou, Adam, Katia Menacho, Anish Bhuva, et al.. (2023). Comparison of the accuracy and reproducibility of AI based echocardiography and CMR analysis for cardiac function assessment in oncology patients at risk of cardiotoxicity. European Heart Journal - Cardiovascular Imaging. 24(Supplement_1). 2 indexed citations

10.

Ioannou, Adam, Marianna Fontana, & Julian D. Gillmore. (2023). RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis. BioDrugs. 37(2). 127–142. 47 indexed citations

11.

Starr, Neasa, Adam Ioannou, & Ana Martinez–Naharro. (2023). Monitoring cardiac amyloidosis with multimodality imaging. Revista Española de Cardiología (English Edition). 77(1). 79–87. 2 indexed citations

12.

Ioannou, Adam, Marianna Fontana, & Julian D. Gillmore. (2023). Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy. Heart International. 17(1). 27–27. 10 indexed citations

13.

Ioannou, Adam, Rishi Patel, Yousuf Razvi, et al.. (2022). Abstract 10064: Tracking Multi-Organ Treatment Response in Systemic Al-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping. Circulation. 146(Suppl_1). 1 indexed citations

14.

Ioannou, Adam. (2022). Iatrogenic adrenaline induced mid-ventricular Takotsubo cardiomyopathy: a case-based review. Irish Journal of Medical Science (1971 -). 192(1). 125–129. 7 indexed citations

15.

Ioannou, Adam, Rishi Patel, Yousuf Razvi, et al.. (2022). Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis. JACC. Cardiovascular imaging. 16(4). 464–477. 28 indexed citations

16.

Ioannou, Adam, Sharon Isralls, Tricia Tan, & David Lefroy. (2021). Thyrotoxic periodic paralysis presenting as a broad complex tachycardia. British Journal of Hospital Medicine. 82(12). 1–3. 1 indexed citations

17.

Παπαγεωργίου, Νικόλαος, Adam Ioannou, Sérgio Barra, et al.. (2019). Full blood count as potential predictor of outcomes in patients undergoing cardiac resynchronization therapy. Scientific Reports. 9(1). 13016–13016. 3 indexed citations

18.

Broyd, Christopher, Vasileios Panoulas, Mohammed Akhtar, et al.. (2018). Effect of Aortic Valve Calcium Quantity on Outcome After Balloon Aortic Valvuloplasty for Severe Aortic Stenosis. The American Journal of Cardiology. 122(6). 1036–1041.

19.

Ioannou, Adam, Νικόλαος Παπαγεωργίου, H. J. Barber, et al.. (2017). Impact of an Age-Adjusted Co-morbidity Index on Survival of Patients With Heart Failure Implanted With Cardiac Resynchronization Therapy Devices. The American Journal of Cardiology. 120(7). 1158–1165. 14 indexed citations

20.

Παπαγεωργίου, Νικόλαος, et al.. (2016). Novel Anti-Platelets in Stable Coronary Artery Disease. Current Pharmaceutical Design. 22(29). 4537–4567. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact